A Post-Marketing Clinical Pharmacokinetics Study Of Gabapentin In Japanese Epileptic Subjects With Renal Impairment

NCT00785772 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

1

Enrollment

INDUSTRY

Sponsor class

Stopped See termination reason in detailed description.

Conditions

Renal Impairment

Interventions

DRUG: Gabapentin
DRUG: Gabapentin
DRUG: Gabapentin

Sponsor

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.